Synergy CHC Corp. (NASDAQ: SNYR) is a consumer health and wellness company whose news flow centers on brand expansion, retail partnerships, financial results, and capital markets activity. The company develops and markets FOCUSfactor®, a clinically studied brain health supplement and functional beverage line, and Flat Tummy®, a women’s wellness and weight management brand.
News updates for SNYR frequently highlight distribution agreements and retail authorizations for FOCUSfactor® supplements and Focus + Energy functional beverages. Recent press releases describe new Direct Store Delivery partnerships with distributors such as AlaBev, Atlantic Importing Company, C&M Sales, Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., which extend beverage and shot availability across regions including Alabama, Southern New England, Maine, Pennsylvania, and Arkansas. Other announcements cover placements with major retailers like Kroger, Wakefern Food Corp., Uniprix, Fortinos, Pilot Flying J, and PriceSmart.
Investors following SNYR news will also see quarterly earnings announcements, where the company reports revenue, gross margin, operating income, net income, and non‑GAAP metrics such as EBITDA and Adjusted EBITDA. These releases often include commentary on profitability trends, distribution wins, and working capital developments. Additional items include governance and leadership changes, such as board appointments, the creation of roles like Head of Strategic Partnerships, and regional leadership hires for Mexico and Latin America.
Capital markets updates, including public offerings of common stock and related underwriting agreements, appear in both SEC filings and accompanying press releases. For anyone tracking SNYR, this news page provides a consolidated view of the company’s operational progress in brain health and functional beverages, its evolving retail footprint, and key regulatory and financial disclosures. Bookmark this feed to monitor new distribution deals, retailer launches, earnings releases, and corporate developments as they are announced.
Synergy CHC Corp (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has announced its participation in the upcoming 37th Annual ROTH Conference. The event will take place from March 16-18, 2025, in Dana Point, California.
The company's management team will be available during the conference for one-on-one meetings with investors. Interested parties are advised to contact their ROTH sales representative to schedule meetings.
Synergy CHC Corp. (NASDAQ: SNYR) reported its Q3 2024 financial results, marking its seventh consecutive profitable quarter. Revenue decreased 34% to $7.1 million compared to $10.8 million in Q3 2023, primarily due to retailer de-inventorying related to FOCUSfactor product rebranding.
Key financial metrics include: gross margin of 67.2% (down from 72.0%), operating income of $1.1 million (down from $2.1 million), and net income of $0.8 million (down from $1.3 million). The company completed its IPO of 1,150,000 shares at $9.00 per share and expanded retail partnerships with BJ's Wholesale Clubs and Publix. Post-IPO, Synergy reduced debt by $3.1 million and added $6.2 million in net cash to its balance sheet.
Synergy CHC Corp. (NASDAQ: SNYR) has scheduled the release of its third quarter 2024 financial results for December 6, 2024, before market opening. The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day, featuring CEO Jack Ross and CFO Stacy Bieber. Participants are encouraged to join the call 15 minutes early, and a webcast replay will be available on the company's website.
Synergy CHC Corp (NASDAQ: SNYR) has completed its initial public offering of 1,150,000 shares of common stock at $9.00 per share. Trading began on the Nasdaq Global Market on October 23, 2024, under ticker 'SNYR'. The company raised approximately $8.4 million in net proceeds after deducting underwriting costs. Underwriters have a 30-day option to purchase up to 172,500 additional shares. The funds will be used to repay related party promissory notes and for general corporate purposes. Roth Capital Partners served as the sole manager for the offering.
Synergy CHC Corp, a provider of consumer health care, beauty, and lifestyle products, has announced the pricing of its initial public offering of 1,150,000 shares at $9.00 per share. Trading will commence on Nasdaq Global Market under symbol 'SNYR' on October 23, 2024. The company expects to receive $8.4 million in net proceeds, potentially reaching $9.9 million if underwriters exercise their option to purchase additional 172,500 shares. Proceeds will be used to repay related party promissory notes and for general corporate purposes. Roth Capital Partners is serving as the sole manager for the offering, which is expected to close on October 24, 2024.